Cataracts are not a mystery. They are not a rare disease requiring cutting-edge research or experimental drugs. The clouding of the eye's natural lens is among
For decades, the public conversation around carbohydrates has been dominated by quantity. How many grams. How many servings. Whether to cut them entirely. But a
When a novel pathogen emerges, the first thing scientists race to collect is not a vaccine or a treatment. It is the virus itself. Whoever shares that biologica
For decades, the scientific consensus on Toxoplasma gondii followed a reassuringly simple narrative: the parasite infects the brain, forms a cyst, and then goes
Libya has become the latest country to receive WHO validation for eliminating trachoma as a public health problem, a milestone that carries weight well beyond i
Every few years, nutritional science lands on a food that seems almost too convenient to be true. Wild blueberries may be the latest, but the evidence building
Five years into Russia's full-scale invasion, Ukraine's health care infrastructure is being eroded not just by the war's physical destruction but by a compoundi
For most of the roughly one million Americans living with Parkinson's disease, the diagnosis arrives late. By the time a neurologist confirms the condition, som
For decades, the dominant story of aging has been one of accumulation and decay: damaged proteins pile up, DNA frays at the edges, and cells slowly lose the abi
Most people have never heard of cerebral amyloid angiopathy. That unfamiliarity is part of what makes it dangerous. A condition marked by the buildup of amyloid